Accelerated Pharma (Accelerated Pharma) Ending Cash Position : $0.06 Mil (As of Mar. 2017)

View and export this data going back to 2016. Start your Free Trial

What is Accelerated Pharma Ending Cash Position?

Accelerated Pharma's Ending Cash Position for the quarter that ended in Mar. 2017 was $0.06 Mil.

Accelerated Pharma's quarterly Ending Cash Position declined from Sep. 2016 ($0.12 Mil) to Dec. 2016 ($0.06 Mil) but then increased from Dec. 2016 ($0.06 Mil) to Mar. 2017 ($0.06 Mil).

Accelerated Pharma's annual Ending Cash Position increased from Dec. 2014 ($0.00 Mil) to Dec. 2015 ($0.66 Mil) but then declined from Dec. 2015 ($0.66 Mil) to Dec. 2016 ($0.06 Mil).

Accelerated Pharma Ending Cash Position Historical Data

The historical data trend for Accelerated Pharma's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerated Pharma Ending Cash Position Chart

Accelerated Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Ending Cash Position

0.66

0.06

Accelerated Pharma Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Ending Cash Position	Get a 7-Day Free Trial			0.23	0.01	0.12	0.06	0.06

Accelerated Pharma Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Accelerated Pharma's Ending Cash Position for the fiscal year that ended in Dec. 2016 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.67	+	-0.608
	=	0.06

Accelerated Pharma's Ending Cash Position for the quarter that ended in Mar. 2017 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.064	+	-0.001
	=	0.06

Accelerated Pharma Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Accelerated Pharma's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Accelerated Pharma (Accelerated Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.

Accelerated Pharma (Accelerated Pharma) Headlines

No Headlines